CCA
APLT

Catalyst Capital Advisors’s Applied Therapeutics APLT Stock Holding History

Catalyst Capital Advisors’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-800
Closed -$7K – 423
2019
Q2 		$7K Buy
+800
New +$7.57K ﹤0.01% 344

Other funds holding APLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Catalyst Capital Advisors's APLT Position: Q3 2019 in Review

Catalyst Capital Advisors sold out of Applied Therapeutics (APLT) in Q3 2019, closing a stake of 800 shares — an estimated $7K sold.

Catalyst Capital Advisors first reported a position in APLT in Q2 2019 and held it in 1 quarter. The position peaked at $7K in Q2 2019. 30 funds tracked by Wall St. Rank hold APLT as of Q3 2019.

  • Catalyst Capital Advisors reported no remaining Applied Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Catalyst Capital Advisors sold 800 Applied Therapeutics shares in Q3 2019, an estimated $7K.
  • Catalyst Capital Advisors first reported a position in Applied Therapeutics in Q2 2019 and held it in 1 quarter.
  • Catalyst Capital Advisors's Applied Therapeutics position peaked at $7K in Q2 2019.
  • 30 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2019.

Based on Catalyst Capital Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.